US Stocks Mixed; Dow Falls 50 Points
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 50 points on Tuesday.
Foghorn Therapeutics Announces FDA Has Placed A Clinical Hold On Phase I Dose Escalation Study Of FHD-286
Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical stage biotechnology company pioneering a new class of medicines that modulate gene expression through selectively targeting the chromatin regulatory system,
4 Analysts Have This to Say About Foghorn Therapeutics
Analysts have provided the following ratings for Foghorn Therapeutics (NASDAQ:FHTX) within the last quarter: